McGrath Lynne Fahey's Form 4/A amendment
AmendedAlzamend Neuro, Inc. (ALZN) · filed Apr 8, 2022
- Accession no.
- 0001214659-22-004992
- Filed
- Apr 8, 2022
- Trade date
- Mar 28, 2022
- Filing delay
- 11 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Apr 6, 2022
This filing lists 1 non-derivative transaction. Open-market sales total $30.3K. It was filed 11 days after the trade.
This amendment replaces 0001214659-22-004914 (filed Apr 6, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McGrath Lynne FaheyCIK 0001866270 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2022 | Common Stock | SSaleDisposed | −25,000 | $1.21F2 | −$30,250 | 75,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4 filed on April 6, 2022, is amended by this Form 4 amendment to correct a typographical error in Table I Column 4 from "A" to "D".
- F2
The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 1 transaction in Table I.